VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
39 hedge funds and large institutions have $67.2M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
11% more funds holding
Funds holding: 35 → 39 (+4)
Holders
39
Holding in Top 10
1
Calls
$37.4M
Puts
$141K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$8.31M | |
| 3 | +$1.66M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.51M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$1.11M |
Top Sellers
| 1 | -$2.83M | |
| 2 | -$438K | |
| 3 | -$217K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$179K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$178K |